west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "YANG Lifeng" 2 results
  • Clinic Observation and Nursing of Treatment of Toxic Epidermal Necrolysis (TEN) with High Dose Glucocorticosteroid combined with Intravenous Immunoglobulin (IVIG)

    目的:观察大剂量的激素联合丙种球蛋白治疗中毒性表皮坏死松解症(TEN)的治疗和护理效果。方法:收集我科2003年1月至2008年9月住院治疗的15例经大剂量激素联合丙种球蛋白治疗的TEN患者,观察治疗及护理效果。结果:15例患者平均住院约17天均痊愈出院。结论:大剂量激素联合丙种球蛋白治疗效果好,同时严格的消毒隔离及皮肤黏膜的护理,对治愈此病起着重要作用。

    Release date:2016-09-08 09:54 Export PDF Favorites Scan
  • The diagnostic value of 18F-FDG PET/CT in epithelial ovarian cancer recurrence: a meta-analysis

    Objective To systematically review the diagnostic value of 18F-FDG PET/CT in recurrent epithelial ovarian cancer after treatment. Methods The PubMed, EMbase, Cochrane Library, Web of Science, CNKI, WanFang Data, VIP, and CBM databases were electronically searched to collect diagnostic tests of 18F-FDG PET/CT for epithelial ovarian cancer from inception to February 2023. Two reviewers independently screened the literature, extracted data, and assessed the risk of bias of the included studies. Meta-analysis was then performed using Meta-Disc 1.4 and Stata 15.0 software. Results A total of 15 studies involving 792 patients were included in this study. The results of meta-analysis showed that the sensitivity, specificity, and area under the curve of 18F-FDG PET/CT in the diagnosis of recurrent epithelial ovarian cancer were 0.88 (95%CI 0.85 to 0.90), 0.80 (95%CI 0.75 to 0.85) and 0.91, respectively. The results of the subgroup analysis showed that the sensitivity of the prospective studies was the same as that of the retrospective studies, but the specificity of the prospective studies was higher than that of the retrospective studies. The diagnostic sensitivity and specificity of 18F-FDG PET/CT in recurrent epithelial ovarian cancer were higher in Asian studies than in European/North American studies. Conclusion 18F-FDG PET/CT has high diagnostic value in recurrent epithelial ovarian cancer. Due to the limited quantity and quality of the included studies, more high-quality studies are needed to verify the above conclusion.

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content